Han-Ting Chang

Title: Han-Ting Chang: Innovator in Ion Imbalance Treatments

Introduction

Han-Ting Chang, based in Livermore, CA, is an accomplished inventor with an impressive portfolio of 32 patents. His work primarily focuses on advancements in medical treatments for ion imbalances, showcasing his dedication to improving health outcomes for patients.

Latest Patents

Among his latest inventions are "Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal" and "Ion binding polymers and uses thereof". The first patent presents innovative methods and compositions using core-shell composites aimed at treating ion imbalances. It emphasizes the development of core-shell particles containing potassium and sodium binding polymers for therapeutic applications. This invention offers enhanced strategies for managing conditions like hyperkalemia and hypertension by regulating potassium and sodium ions in the body. The second patent focuses on the formulation of potassium binding polymers and their pharmaceutical applications, particularly in treating hyperkalemia resulting from renal failure or certain medications.

Career Highlights

Throughout his career, Han-Ting has made significant contributions in the field of biomedical technology. He has been affiliated with reputable companies, including Relypsa, Inc. and Ardelyx, Inc. His efforts have led to substantial advancements in the development of effective treatments for ion imbalance disorders, reinforcing his status as a leader in the industry.

Collaborations

Han-Ting Chang has collaborated with notable colleagues, including Dominique Charmot and Mingjun Liu. These partnerships have fostered a creative environment conducive to innovation, allowing them to tackle complex medical issues related to ion homeostasis collectively.

Conclusion

In summary, Han-Ting Chang's contributions to the field of ion imbalance treatment exemplify his commitment to innovation and improving patient care. With a robust portfolio of patents and meaningful collaborations, he continues to make a lasting impact in the medical and pharmaceutical sectors. His work not only enhances understanding of ion transport mechanisms but also opens new avenues for therapeutic interventions.